Lu Cheng
Sichuan University
9 Papers
15 Citations
Lu Cheng is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 6 publications.
Chat about Author
Papers
Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation.
TL;DR: In this paper, the authors investigated the underlying mechanism of fisetin and found that it improved kidney function, ameliorated renal fibrosis, and restored enteric dysbacteriosis in hyperuricemia-induced chronic kidney disease.
39
The relationship between thyroid dysfunction and nephrotic syndrome: a clinicopathological study.
TL;DR: It is demonstrated that the type of renal pathology was different among NS patients in different thyroid dysfunction subgroups, and high levels of urinary protein, creatinine, cholesterol, and platelets were independent risk factors predicting thyroid dysfunction, while higher albumin and hemoglobin were protective factors.
Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy.
TL;DR: It is highlighted that activation of GPR120 in podocytes ameliorates renal inflammation and fibrosis to protect against DN.
33
Toll-like Receptors as Potential Therapeutic Targets in Kidney Diseases.
TL;DR: New evidence is reviewed on roles of TLRs in the pathogenesis of kidney diseases including urinary tract infection, glomerulonephritis, acute kidney injury, transplant allograft dysfunction and chronic kidney diseases.
14
Double Filtration Plasmapheresis in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Dysfunction
TL;DR: DFPP may be a choice of plasmapheresis for AAV patients with severe kidney injury especially in countries and regions with limited blood resources, as suggested in this study.
5